172 related articles for article (PubMed ID: 4609140)
1. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
Zigmond MJ; Stricker EM
Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
[No Abstract] [Full Text] [Related]
2. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Cooper BR; Breese GR
Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
[No Abstract] [Full Text] [Related]
3. 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine.
Björklund A; Baumgarten HG; Rensch A
J Neurochem; 1975 Apr; 24(4):833-5. PubMed ID: 1123645
[No Abstract] [Full Text] [Related]
4. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
Cooper BR; Breese GR; Grant LD; Howard JL
J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
[No Abstract] [Full Text] [Related]
5. Catecholamines, drugs, and behavior: mutual interactions.
Seiden LS; Campbell AB
Adv Biochem Psychopharmacol; 1974; 12(0):325-38. PubMed ID: 4418348
[No Abstract] [Full Text] [Related]
6. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
Moore KE
Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
[No Abstract] [Full Text] [Related]
7. Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion.
Zigmond MJ; Stricker EM
Experientia; 1980 Apr; 36(4):436-8. PubMed ID: 7379917
[TBL] [Abstract][Full Text] [Related]
8. Biochemical aspects of dopamine agonists.
Kehr W; Carlsson A; Lindqvist M
Adv Neurol; 1975; 9():185-95. PubMed ID: 1146653
[No Abstract] [Full Text] [Related]
9. [Characteristics and functions of intraneuronal compartments of monoamines in the central nervous system].
Gowinski J; Besson MJ; Cheramy A; Javoy F; Thierry AM
Rev Neurol (Paris); 1972 Jul; 127(1):1-22. PubMed ID: 4677511
[No Abstract] [Full Text] [Related]
10. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
Zigmond MJ; Stricker EM
Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
[TBL] [Abstract][Full Text] [Related]
11. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
Stricker EM; Zigmond MJ
J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
[No Abstract] [Full Text] [Related]
12. Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine.
Cooper BR; Howard JL; Grant LD; Smith RD; Breese GR
Pharmacol Biochem Behav; 1974; 2(5):639-49. PubMed ID: 4610593
[No Abstract] [Full Text] [Related]
13. Effect of chronic treatment with central stimulants on brain monoamines and some behavioral and physiological functions in rats, guinea pigs, and rabbits.
Lewander T
Adv Biochem Psychopharmacol; 1974; 12(0):221-39. PubMed ID: 4607740
[No Abstract] [Full Text] [Related]
14. Effect of central catecholamine depletions by 6-hydroxydopamine on morphine antinociception in rats.
Elchisak MA; Rosecrans JA
Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):349-52. PubMed ID: 4734013
[No Abstract] [Full Text] [Related]
15. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
Bannon MJ; Bunney EB; Roth RH
Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
[TBL] [Abstract][Full Text] [Related]
16. Learning, brain noradrenaline and the pituitary--adrenal axis.
Ogren SO; Fuxe K
Med Biol; 1974 Dec; 52(6):399-405. PubMed ID: 4374613
[No Abstract] [Full Text] [Related]
17. Altered ontogenesis of central noradrenergic neurons following neonatal treatment with 6-hydroxydopamine.
Singh B; Champlain J
Brain Res; 1972 Dec; 48():432-7. PubMed ID: 4645216
[No Abstract] [Full Text] [Related]
18. Effects of alterations in impulse flow on transmitter metabolism in central dopaminergic neurons.
Roth RH; Walters JR; Morgenroth VH
Adv Biochem Psychopharmacol; 1974; 12(0):369-84. PubMed ID: 4153663
[No Abstract] [Full Text] [Related]
19. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
Iwamoto ET; Ho IK; Way EL
J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
[No Abstract] [Full Text] [Related]
20. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
Wurtman RJ
Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
